During a home visit the nurse suspects that a newborn is experiencing chlamydial conjunctivitis. What did the nurse assess to make this clinical determination? Select all that apply
1. Eyelid swelling
2. Yellow discharge
3. Eye inflammation
4. Purulent discharge
5. Corneal ulcerations
1, 2, 3
Explanation:
1. Manifestations of chlamydial conjunctivitis include eyelid swelling 5 to 14 days after birth.
2. Manifestations of chlamydial conjunctivitis include yellow discharge.
3. Manifestations of chlamydial conjunctivitis include eye inflammation.
4. Purulent discharge is a manifestation of ophthalmia neonatorum caused by gonorrhea.
5. Corneal ulceration is a manifestation of ophthalmia neonatorum caused by gonorrhea.
You might also like to view...
Which strategy is most likely to increase participation in the use of evidence-based practice in nursing?
1. Ensure adequate training and encourage its use by the nursing staff. 2. Elicit employee opinions of its use at least four times per year. 3. Give those nurses willing to use it extra recognition. 4. Ensure adequate training, recognition, and easy access to the Internet.
To prepare a time tape for a bag of IV solution, the nurse must note:
a. the infusion rate and approximate infusion intervals b. date and time infusion was started c. initials of person preparing time tape d. the name of the solution, manufacturer, infusion rate, and expected time of completion
An outpatient has been self-monitoring blood pressure readings since beginning reserpine for hypertension 3 days ago. The patient reports, "My blood pressure has not changed since I started taking the medication"
The nurse should advise the patient: a. "Take an extra dose now and recheck the blood pressure tomorrow." b. "Discontinue the medication and come to the office immediately." c. "This is normal. The effects may not be evident for a full week." d. "Another medication is needed with the treatment regimen."
You are consulted on the choice of drug to give a patient. You believe that a drug targeted to DNA is the best class of drug in this setting, but the patient has been heavily pretreated with other cytotoxic drugs and is still recovering from bone marrow damage. Which drug would be the best choice due to its moderate myelosuppression side effect?
A. Cisplatin B. Etoposide C. Carmustine D. Mitoxantrone